0 results for 'Roche Holding Ltd'
Daily Decision Service Alert: Vol. 21, No. 197 – October 9, 2012
Daily decision alert.The Am Law 100, the Early Numbers: Amid Partner Growth Spurt, Weil's Profits Drop
A year that saw Weil, Gotshal & Manges expand its partnership ranks significantly ended with the firm's gross revenues essentially flat at $1.229 billion and its profits per partner down 8.6 percent to $1.86 million, according to The American Lawyer's reporting.View more book results for the query "Roche Holding Ltd"
Publishing Clinical Trial Data Could Affect Patents
Imagine that a company marketing a new drug ran tests that showed a kidney failure risk, but didn't make the risk public. Now imagine there's a law that would force the drug company to tell the public about every test it conducted on the drug. If certain policymakers and interest groups get their way, such a law could soon become a reality. While this may be a boon for doctors and patients alike, pharmaceutical companies need to keep a watchful eye on how this could affect their patent rights.Preclinical use of research tool is infringement
The biotechnology industry has been given new life, and the drug pipeline can keep flowing. In a case of first impression closely watched by the biotechnology and pharmaceutical industries, the U.S. Court of Appeals for the Federal Circuit held on June 6, in Integra Lifesciences I Ltd. v. Merck KGaA, nos. 02-1052, 02-1065, 2003 U.S. App. Lexis 11335 (Fed. Cir. June 6, 2003), that preclinical use of a patented research tool for drug discovery is patent infringement and is not protected under the safe harborState AI Legislation Is on the Move in 2024
Brought to you by LexisNexis®
Download Now
2024 ESI Risk Management & Litigation Readiness Report
Brought to you by Pagefreezer
Download Now
Creating a Culture of Compliance
Brought to you by Ironclad
Download Now
A Buyer's Guide to Law Firm Software
Brought to you by PracticePanther
Download Now